story of the week
Short-Course vs No Androgen Deprivation Therapy Added to Postoperative Radiotherapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
Lancet 2024 May 16;[EPub Ahead of Print], CC Parker, NW Clarke, AD Cook, H Kynaston, CN Catton, WR Cross, PM Petersen, RA Persad, F Saad, LC Bower, J Logue, H Payne, S Forcat, C Goldstein, C Murphy, J Anderson, M Barkati, DM Bottomley, J Branagan, A Choudhury, PWM Chung, L Cogley, CL Goh, P Hoskin, V Khoo, SC Malone, L Masters, SL Morris, A Nabid, AD Ong, R Raman, KL Tarver, AC Tree, J Worlding, JP Wylie, AM Zarkar, WR Parulekar, MKB Parmar, MR SydesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.